Latest Breaking News On - ஆழமான லென்ஸ் - Page 2 : comparemela.com

The CenterTX to deploy Deep Lens’ AI-based solution for clinical trials 04 Jun 2021 (Last Updated June 4th, 2021 16:32) VIPER can identify qualified patients for clinical trials by integrating into The CenterTX’s molecular data feeds directly. Share Article VIPER will use cloud-based technology to facilitate and accelerate the clinical trial recruitment process. Credit: Michal Jarmoluk from Pixabay. The Center for Cancer and Blood Disorders (The CenterTX) in the US is set to deploy Deep Lens’ artificial intelligence (AI)-based clinical trial screening and enrolment solution VIPER. Using Cloud-based technology, VIPER will facilitate, triage, and accelerate the clinical trial recruitment process. Through its partnership with Deep Lens, The CenterTX will broaden its clinical trial offering by improving efficiencies related to recruitment and expanding the number of available trials for eligible subjects.

United statesGreg andreolaBarry russoBlood disordersDeep lenDeep lensHematology specialistsஒன்றுபட்டது மாநிலங்களில்பாரி ருஸ்ஸோஇரத்தம் கோளாறுகள்ஆழமான லென்ஆழமான லென்ஸ்ஹீமாட்டாலஜி வல்லுநர்கள்